Opioid Overuse and Adverse Effects on the Rise in US Children
September 20th 2017Opioid-related problems, such as adverse reactions and opioid dependency, are increasing among children in the United States, according to 2 study abstracts presented at the recent American Academy of Pediatrics 2017 National Conference in Chicago.
New Indication for Diabetes Drug to Reduce CV Risk
August 25th 2017Officials with the FDA have approved a new indication for liraglutide (Victoza, Novo Nordisk), according to a press release from Novo. The updated indication makes Victoza the only type 2 diabetes drug indicated to reduce the risk of major adverse cardiovascular events.
More Evidence Needed for Cannabis Use in Patients with PTSD, Chronic Pain
August 17th 2017In 2 reviews recently published in the Annals of Internal Medicine, researchers analyzed ongoing studies aimed at plant-based cannabis’ medicinal benefits, including use in chronic pain and posttraumatic stress disorder (PTSD).
FDA Advises Against Use of Liquid Drug Products Due to Burkholderia Cepacia Contamination
August 9th 2017Officials with the FDA have issued a safety alert advising health care professionals and patients against the use of any liquid product manufactured by PharmaTech LLC, Davie, Florida, due to possible Burkholderia cepacia contamination.
Survey: NPs Spend At Least Half of Appointment Time on Patient Education
August 2nd 2017Educating patients about various medical conditions, and correcting medical misinformation that patients may be researching on their own in places like the Internet comprises a large portion of a nurse practitioner’s day, according to the findings of a recent Merck Manuals survey.
FDA Approves First Oral Treatment for Relapsed, Refractory Acute Myeloid Leukemia
August 1st 2017Officials with the FDA have approved enasidenib (Idhifa, Celgene Corporation) for the treatment relapsed or refractory acute myeloid leukemia (AML) in adult patients who have a specific genetic mutation, isocitrate dehydrogenase-2 (IDH2), according to a FDA press release.